SCHEMBL1226894

SCHEMBL1226894

Cc1cc2c(F)c(Oc3ncnn4cc(C(=O)O)c(C)c34)ccc2[nH]1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 15/20 0.83
▸ CYP3A4 P08684 12/20 0.67
▸ FGFR1 P11362 5/20 0.67
▸ KCNH2 Q12809 3/20 0.67
▸ STK10 O94804 2/20 0.67
▸ MAP4K4 O95819 2/20 0.67
▸ RET P07949 2/20 0.67
▸ PDGFRB P09619 2/20 0.67
▸ DDR1 Q08345 2/20 0.67
▸ SLK Q9H2G2 2/20 0.67
▸ EPHB6 O15197 1/20 0.67
▸ RIPK2 O43353 1/20 0.67
▸ ABL1 P00519 1/20 0.67
▸ EGFR P00533 1/20 0.67
▸ LCK P06239 1/20 0.67
▸ CSF1R P07333 1/20 0.67
▸ HCK P08631 1/20 0.67
▸ KIT P10721 1/20 0.67
▸ SRC P12931 1/20 0.67
▸ PDGFRA P16234 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1226328 0.89 KDR (0.83) KDRCYP3A4FGFR1KCNH2STK10
SCHEMBL1226910 0.86 KDR (1.00) KDRCYP3A4FGFR1KCNH2STK10
SCHEMBL12020489 0.86 KDR (0.81) KDRCYP3A4FGFR1KCNH2STK10
SCHEMBL32664265 0.85 KDR (0.61) KDRCYP3A4FGFR1KCNH2STK10
SCHEMBL1227590 0.84 KDR (0.75) KDRCYP3A4FGFR1KCNH2STK10
SCHEMBL1227665 0.83 KDR (0.77) KDRCYP3A4FGFR1KCNH2STK10
SCHEMBL13412328 0.83 KDR (0.70) KDRCYP3A4FGFR1KCNH2STK10
SCHEMBL1227092 0.83 KDR (0.73) KDRCYP3A4FGFR1KCNH2STK10
Potassium Ion SCHEMBL4869310 0.83 KDR (0.76) KDRCYP3A4FGFR1KCNH2STK10
SCHEMBL1227648 0.83 KDR (0.75) KDRCYP3A4FGFR1KCNH2STK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1534290-B1 NOVEL INHIBITORS OF KINASES BRISTOL MYERS SQUIBB CO (US) 2011-12-21 — — EP disclosed
EP-2280012-A2 Pyrrolo[2,1-f][1,2,4]triazine derivatives as kinase inhibitors Bristol-Myers Squibb Company (US) 2011-02-02 — — EP disclosed
Send feedback